Research recommendation(s) from an individual piece of guidance
|Guidance:||Pregnancy (rhesus negative women) - routine anti-D (review)|
|Date issued:||August 2008|
Research recommendations coming out of this guidance
- Head-to-head trials of single-dose versus two-dose [routine antenatal anti-D prophylaxis] (RAADP) regimens are required to establish relative efficacy.
- A study to better estimate the disutility of fetal and neonatal loss, as well as the disutility to parents who experience such a loss, is required.
This page was last updated: 10 March 2014